Parents
Sign in to add mentor| Isabelle van Seuningen | grad student | 2007 | Lille 2 | |
| (Rôles des mucines MUC1 et MUC4 dans l'adénocarcinome de l'oesophage : études in vitro, ex vivo et dans un modèle animal de carcinogenèse induite) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| von Holzen U, Schmidt S, Hayoz S, et al. (2020) Surgical Outcomes After Neoadjuvant Chemoradiation Followed by Curative Surgery in Patients With Esophageal Cancer: An Intergroup Phase lll Trial of the Swiss Group for Clinical Cancer Research (SAKK 75/08). Annals of Surgery |
| Baiocchi GL, Giacopuzzi S, Reim D, et al. (2020) Incidence and Grading of Complications after Gastrectomy for Cancer Using the GASTRODATA Registry: A European Retrospective Observational Study. Annals of Surgery |
| Doussot A, Vernerey D, Rullier E, et al. (2020) Surgical Management and Outcomes of Rectal Cancer with Synchronous Prostate Cancer: A Multicenter Experience from the GRECCAR Group. Annals of Surgical Oncology |
| Pasquer A, Gronnier C, Piessen G. (2020) What are the Particularities of Gastric and Bariatric Surgery in the Cirrhotic Patient. Chirurgia (Bucharest, Romania : 1990). 115: 161-168 |
| Bencivenga M, Treppiedi E, Dal Cero M, et al. (2020) The amount of signet ring cells is significantly associated with tumour stage and survival in gastric poorly cohesive tumours. Journal of Surgical Oncology |
| Cohen R, Pudlarz T, Garcia-Larnicol ML, et al. (2020) [Localized MSI/dMMR gastric cancer patients, perioperative immunotherapy instead of chemotherapy: The GERCOR NEONIPIGA phase II study is opened to recruitment]. Bulletin Du Cancer |
| Aparicio T, Henriques J, Manfredi S, et al. (2020) Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patients. International Journal of Cancer |
| Karoui M, Rullier A, Piessen G, et al. (2020) Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers: A Phase II Multicenter Randomized Controlled Trial (PRODIGE 22). Annals of Surgery. 271: 637-645 |
| Eveno C, Voron T, Piessen G. (2020) Correction to: Laparoscopic Hyperthermic Intraperitoneal Chemotherapy for Patients with Gastric Peritoneal Metastases: Limitations and Perspectives. Annals of Surgical Oncology. 26: 889 |
| Karoui M, Gallois C, Piessen G, et al. (2020) Does neoadjuvant FOLFOX chemotherapy improve the oncological prognosis of high-risk stage II and III colon cancers ? Three years’ follow-up results of the Prodige 22 phase II randomized multicenter trial. Journal of Clinical Oncology. 38: 4110-4110 |